Skip to main content

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Urcuyo Delgado, Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Veronica del Carmen Gil Garcia

Veronica del Carmen Gil Garcia

Quality, Processes and Document Management Unit
Digital Transformation Directorate
Read more
Joan Roig Soriano

Joan Roig Soriano

Main researcher
Gene Therapy at Nervous System
Read more
Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Marquez Parra, Jose David

Marquez Parra, Jose David

Maintenance staff and general services
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.